1. Home
  2. HRMY vs PRLB Comparison

HRMY vs PRLB Comparison

Compare HRMY & PRLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

SELL

Current Price

$38.04

Market Cap

2.4B

Sector

Health Care

ML Signal

SELL

Logo Proto Labs Inc.

PRLB

Proto Labs Inc.

SELL

Current Price

$84.89

Market Cap

2.0B

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
HRMY
PRLB
Founded
2017
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.0B
IPO Year
2020
2011

Fundamental Metrics

Financial Performance
Metric
HRMY
PRLB
Price
$38.04
$84.89
Analyst Decision
Buy
Buy
Analyst Count
12
5
Target Price
$48.25
★ $95.50
AVG Volume (30 Days)
★ 750.6K
194.6K
Earning Date
11-03-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
7.97
★ 33.33
EPS
★ 1.84
0.71
Revenue
★ $868,453,000.00
N/A
Revenue This Year
$18.62
$9.25
Revenue Next Year
$13.23
$7.56
P/E Ratio
★ $20.62
$120.74
Revenue Growth
★ 21.51
N/A
52 Week Low
$25.81
$45.10
52 Week High
$43.49
$99.96

Technical Indicators

Market Signals
Indicator
HRMY
PRLB
Relative Strength Index (RSI) 42.84 39.18
Support Level $37.48 $77.11
Resistance Level $39.35 $93.00
Average True Range (ATR) 1.28 3.31
MACD -0.24 -1.49
Stochastic Oscillator 50.52 4.07

Price Performance

Historical Comparison
HRMY
PRLB

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About PRLB Proto Labs Inc.

Proto Labs Inc is an on-demand manufacturer of custom parts for prototyping and short-run production. The company offers developers and engineers quick-turn production services to reduce the time to market. The Lab uses injection molding, computer numerical control machining, and 3-D printing, and sheet metal to manufacture custom parts for its clients. The company services clients' needs for prototype solutions, parts for testing procedures, bridge production capabilities during disruptions in manufacturing processes, limited-quantity requests, and end-of-life production support. Geographically, a majority of the company's revenue is derived from the United States and the rest from Europe.

Share on Social Networks: